Effect of Clarithromycin, a Strong CYP3A and P-glycoprotein Inhibitor, on the Pharmacokinetics of Edoxaban in Healthy Volunteers and the Evaluation of the Drug Interaction with Other Oral Factor Xa Inhibitors by a Microdose Cocktail Approach

Alexander Lenard, Simon A Hermann, Felicitas Stoll, Juergen Burhenne, Kathrin I Foerster, Gerd Mikus, Andreas D. Meid, Walter E Haefeli, Antje Blank
August 2024
PDF DOI
Type
Journal article
Publication
Cardiovasc Drugs Ther 2024;38:747-756
Source Themes
Andreas D. Meid
Andreas D. Meid
Post-doctoral researcher in Clinical Pharmacology & Pharmacoepidemiology

My research interests include the study of appropriate drug therapy using methods of pharmacoepidemiology, quantitative pharmacology, and pharmacometrics.

Related